The Role of Inflammatory, Anti-Inflammatory, and Regulatory Cytokines in Patients Infected with Cutaneous Leishmaniasis in Amazonas State, Brazil

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Espir, Thaís Tibery ^a,b   Figueira, Luanda De Paula ^a   Naiff, Maricleide De Farias ^a   Da Costa, Allyson Guimarães ^b,c   Ramalho Ortigão, Marcelo ^d   Malheiro, Adriana ^b,c   Franco, Antonia Maria Ramos ^a  

^a INSTITUTO NACIONAL DE PESQUISAS DA AMAZÔNIA   (Brazil)

^b FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^c Fundacao de Hematologia e Hemoterapia do Amazonas   (Brazil)

^d KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAZIL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LEISHMANIA; LEISHMANIA NAIFFI; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SKIN LEISHMANIASIS; ADOLESCENT; BLOOD; CLASSIFICATION; FLOW CYTOMETRY; HOST PARASITE INTERACTION; IMMUNOLOGY; MIDDLE AGED; PARASITOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; BRAZIL; CYTOKINES; FEMALE; FLOW CYTOMETRY; HOST-PARASITE INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; LEISHMANIA; LEISHMANIA GUYANENSIS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84931447647     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/481750     Document Type: Article

References (53)

1. J. Alvar, I. D. Vélez, C. Bern et al., "Leishmaniasis worldwide and global estimates of its incidence, " PLoS ONE, vol. 7, no. 5, Article ID e35671, 2012.
2. F. T. Silveira, R. Lainson, and C. E. P. Corbett, "Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil - a review, " Memorias do Instituto Oswaldo Cruz, vol. 99, no. 3, pp. 239-251, 2004.
3. SINAN/SVS/MS, Boletim Eletrônico Epidemiológigo, 2012.
4. F. T. Silveira, E. A. Y. Ishikawa, A. A. A. de Souza, and R. Lainson, "An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil, caused by Leishmania (Viannia) lindenbergi n. sp. A new leishmanial parasite of man in the Amazon region, " Parasite, vol. 9, no. 1, pp. 43-50, 2002.
5. M. F. Naiff, E. Cupolillo, R. D. Naiff, H. Momen, T. V. Barret, and J. R. G. Grimaldi, "Leishmaniose tegumentar americanana Amazônia: distribuição geográfica dos agentes etiológicos naregião, " Revista da Sociedade Brasileira de Medicina Tropical, vol. 32, article 243, supplement 1, 1999.
6. L.D. P. Figueira, M. Zanotti, F. G. Pinheiro, and A. M. R. Franco, "Isoenzymatic characterization of human isolates of Leishmania sp (Kinetoplastida: Trypanosomatidae) fromthemunicipalities of Rio Preto da Eva and Manaus, State of Amazonas, " Revista da Sociedade Brasileira de Medicina Tropical, vol. 41, no. 5, pp. 512-514, 2008.
7. J. Maüel, "Vaccination against Leishmania infections, " Current Drug Targets: Immune, Endocrine and Metabolic Disorders, vol. 2, no. 3, pp. 201-226, 2002.
8. F. T. Silveira, S. R. Mülher, A. A. Souza, R. Lainson, C. M. Gomes, and M. D. Laurent, "Revisão sobre a patogenia da Leishmaniose Tegumentar Americana na Amazônia, com ěnfase à doença causada por Leishmania (V.) braziliensis e Leishmania (L.) amazonensis, " Revista Paraense de Medicina, vol. 22, pp. 9-20, 2008.
9. B. Gontijo and M. L. R. Carvalho, "Leishmaniose Tegumentar Americana, " Revista da Sociedade Brasileira de Medicina Tropical, vol. 36, no. 1, pp. 71-80, 2003.
10. D. B. Prates, T. Aráujo-Santos, N. F. Luz et al., "Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils, " Journal of Leukocyte Biology, vol. 90, no. 3, pp. 575-582, 2011.
11. D. Sacks and N. Noben-Trauth, "The immunology of susceptibility and resistance to Leishmania major in mice, " Nature Reviews Immunology, vol. 2, no. 11, pp. 845-858, 2002.
12. N. Wanasen and L. Soong, "L-arginine metabolism and its impact on host immunity against Leishmania infection, " Immunologic Research, vol. 41, no. 1, pp. 15-25, 2008.
13. R. A. Oliveira, C. G. Lima, R. M. Mota et al., "Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial, " BMC Nephrology, vol. 13, no. 1, article 44, 2012.
14. G. A. S. Romero, M. V. de Farias Guerra, M. G. Paes, and V. de Oliveira Macědo, "Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and Leishmania (V.) guyanensis in Brazil: Therapeutic response to meglumine antimoniate, " American Journal of Tropical Medicine and Hygiene, vol. 65, no. 5, pp. 456-465, 2001.
15. J. Arevalo, L. Ramirez, V. Adaui et al., "Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis, " The Journal of Infectious Diseases, vol. 195, no. 12, pp. 1846-1851, 2007.
16. Ministério da Sáude (Brasil) and Secretaria da Vigilância em Sáude, Manual de Vigilância da Leishmaniose Tegumentar Americana, vol. 2, Ministério da Sáude, 2007, http://portal.saude. gov.br/portal/arquivos/pdf/manual lta 2ed.pdf.
17. F. G. Novy and W. J. MacNeal, "On the cultivation of Trypanosoma brucei, " The Journal of Infectious Diseases, vol. 1, no. 1, pp. 1-30, 1904.
18. G. L.Nicolle, "Culture du parasite du Bouton d'Orient, " Comptes Rendus de l'Académie des Sciences, vol. 146, pp. 842-843, 1908.
19. E. Cupolillo, G. Grimaldi Jr., and H. Momen, "A general classification of new world Leishmania using numerical zymotaxonomy, " The American Journal of Tropical Medicine and Hygiene, vol. 50, no. 3, pp. 296-311, 1994.
20. W. S. Alexander and D. J. Hilton, "The role of suppressors of cytokine signaling (SOCS) proteins in regulation of theimmune response, " Annual Review of Immunology, vol. 22, pp. 503-529, 2004.
21. F.O. Martinez, L. Helming, and S. Gordon, "Alternative activation of macrophages: an immunologic functional perspective, " Annual Review of Immunology, vol. 27, pp. 451-483, 2009.
22. C. Bogdan, M. Röllinghoff, and A. Diefenbach, "The role of nitric oxide in innate immunity, " Immunological Reviews, vol. 173, pp. 17-26, 2000.
23. K. J. Rautajoki, M. K. Kyläniemi, S. K. Raghav, K. Rao, and R. Lahesmaa, "An insight into molecular mechanisms of human T helper cell differentiation, " Annals ofMedicine, vol. 40, no. 5, pp. 322-335, 2008.
24. G. E. Kaiko, J. C. Horvat, K. W. Beagley, and P. M. Hansbro, "Immunological decision-making: how does the immune system decide to mount a helper T-cell response?" Immunology, vol. 123, no. 3, pp. 326-338, 2008.
25. A. Ribeiro-de-Jesus, R. P. Almeida, H. Lessa, O. Bacellar, and E. M. Carvalho, "Cytokine profile and pathology in human leishmaniasis, " Brazilian Journal of Medical and Biological Research, vol. 31, no. 1, pp. 143-148, 1998.
26. R. Reithinger, J.-C. Dujardin, H. Louzir, C. Pirmez, B. Alexander, and S. Brooker, "Cutaneous leishmaniasis, " The Lancet Infectious Diseases, vol. 7, no. 9, pp. 581-596, 2007.
27. S. Nylén and S. Gautam, "Immunological perspectives of leishmaniasis, " Journal of Global Infectious Diseases, vol. 2, no. 2, pp. 135-146, 2010.
28. H. W. Murray, C. M. Lu, S. Mauze et al., "Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy, " Infection and Immunity, vol. 70, no. 11, pp. 6284-6293, 2002.
29. G. Trinchieri, "Interleukin-10 production by effector T cells:Th1 cells show self control, " Journal of Experimental Medicine, vol. 204, no. 2, pp. 239-243, 2007.
30. O. Bacellar, H. Lessa, A. Schriefer et al., "Up-regulation of Th1-type responses inmucosal leishmaniasis patients, " Infection and Immunity, vol. 70, no. 12, pp. 6734-6740, 2002.
31. A.Degrossoli, W.W. Arrais-Silva, M. C. Colhone, F. R. Gadelha, P. P. Joazeiro, and S. Giorgio, "The influence of low oxygen on macrophage response to Leishmania infection, " Scandinavian Journal of Immunology, vol. 74, no. 2, pp. 165-175, 2011.
32. S. L. Reiner and R.M. Locksley, "The regulation of immunity to Leishmania major, " Annual Review of Immunology, vol. 13, pp. 151-177, 1995.
33. F. Y. Liew, X.-Q. Wei, and L. Proudfoot, "Cytokines and nitric oxide as effector molecules against parasitic infections, " Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 352, no. 1359, pp. 1311-1315, 1997.
34. R. O. Pinheiro and B. Rossi-Bergmann, "Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 mice, " Memorias do Instituto Oswaldo Cruz, vol. 102, no. 1, pp. 79-82, 2007.
35. P. E. Kima and L. Soong, "Interferon gamma in leishmaniasis, " Frontiers in Immunology, vol. 4, article 156, 2013.
36. A. Latifynia, A. Khamesipour, S. Bokaie, and N. Khansari, "Antioxidants and proinflamatory cytokines in the sera of patients with cutaneous leishmaniasis, " Iranian Journal of Immunology, vol. 9, no. 3, pp. 208-214, 2012.
37. J. K. Kolls and A. Lindén, "Interleukin-17 family members and inflammation, " Immunity, vol. 21, no. 4, pp. 467-476, 2004.
38. S. L. Kostka, S. Dinges, K. Griewank, Y. Iwakura, M. C. Udey, and E. Von Stebut, "IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice, " The Journal of Immunology, vol. 182, no. 5, pp. 3039-3046, 2009.
39. W.-W. Lee, S. W. Kang, J. Choi et al., "Regulating human Th17 cells via differential expression of IL-1 receptor, " Blood, vol. 115, no. 3, pp. 530-540, 2010.
40. O. Bacallar, D. Faria, M. Nascimento et al., "Interleukin 17 production among patients with American cutaneous leishmaniasis, " Journal of Infectious Diseases, vol. 200, no. 1, pp. 75-78, 2009.
41. L. L. Bueno, C. G. Morais, M. V. Lacerda, R. T. Fujiwara, and É. M. Braga, "Interleukin-17 producing T helper cells are increased during natural Plasmodium vivax infection, " Acta Tropica, vol. 123, no. 1, pp. 53-57, 2012.
42. V. S. Boaventura, C. S. Santos, C. R. Cardoso et al., "Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines, " European Journal of Immunology, vol. 40, no. 10, pp. 2830-2836, 2010.
43. 2 cell-associated cytokines in experimental visceral Leishmaniasis, " Infection and Immunity, vol. 62, no. 3, pp. 1058-1063, 1994.
44. R. Hurdayal and F. Brombacher, "The role of IL-4 and IL-13 in cutaneous Leishmaniasis, " Immunology Letters, 2014.
45. L. Siewe, M. Bollati-Fogolin, C. Wickenhauser, T. Krieg, W. Müller, and A. Roers, "Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA, " European Journal of Immunology, vol. 36, no. 12, pp. 3248-3255, 2006.
46. R. Sabat, "IL-10 family of cytokines, " Cytokine and Growth Factor Reviews, vol. 21, no. 5, pp. 315-324, 2010.
47. + regulatory T cells in reactivation of persistent Leishmaniasis and control of concomitant immunity, " Journal of ExperimentalMedicine, vol. 200, no. 2, pp. 201-210, 2004.
48. Y. Belkaid, "Regulatory T cells and infection: a dangerous necessity, " Nature Reviews Immunology, vol. 7, no. 11, pp. 875-888, 2007.
49. R. C. Bittar, R. S. Nogueira, R. Vieira-Gonçalves et al., "T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis, " Memorias do Instituto Oswaldo Cruz, vol. 102, no. 5, pp. 625-630, 2007.
50. Y. Belkaid, K. F. Hoffmann, S. Mendez et al., "The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure, " Journal of Experimental Medicine, vol. 194, no. 10, pp. 1497-1506, 2001.
51. E. P. Kaye and P. Scott, "Leishmaniasis: complexity at the hostpathogen interface, " Nature Reviews Microbiology, vol. 9, no. 8, pp. 604-615, 2011.
52. L. C. Reis, M. E. F. Brito, M. A. Souza et al., "Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment, " Journal of Clinical Laboratory Analysis, vol. 23, no. 1, pp. 63-69, 2009.
53. P. Scott, "Leishmania - a parasitized parasite, " The New England Journal of Medicine, vol. 364, no. 18, pp. 1773-1774, 2011.